Latest news with #HLF
Yahoo
23-05-2025
- Business
- Yahoo
When Should You Buy Herbalife Ltd. (NYSE:HLF)?
Herbalife Ltd. (NYSE:HLF), is not the largest company out there, but it led the NYSE gainers with a relatively large price hike in the past couple of weeks. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's examine Herbalife's valuation and outlook in more detail to determine if there's still a bargain opportunity. Our free stock report includes 4 warning signs investors should be aware of before investing in Herbalife. Read for free now. Good news, investors! Herbalife is still a bargain right now. According to our valuation, the intrinsic value for the stock is $9.20, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Another thing to keep in mind is that Herbalife's share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again. See our latest analysis for Herbalife Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected next year, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Herbalife, at least in the near future. Are you a shareholder? Although HLF is currently undervalued, the adverse prospect of negative growth brings about some degree of risk. We recommend you think about whether you want to increase your portfolio exposure to HLF, or whether diversifying into another stock may be a better move for your total risk and return. Are you a potential investor? If you've been keeping an eye on HLF for a while, but hesitant on making the leap, we recommend you dig deeper into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Every company has risks, and we've spotted 4 warning signs for Herbalife (of which 3 are a bit concerning!) you should know about. If you are no longer interested in Herbalife, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
14-05-2025
- Business
- Yahoo
HLF Q1 Earnings Call: Herbalife Outlines Tech Transformation Amid Revenue Miss
Health and wellness products company Herbalife (NYSE:HLF) missed Wall Street's revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $1.22 billion. On the other hand, the company expects next quarter's revenue to be around $1.26 billion, close to analysts' estimates. Its non-GAAP profit of $0.59 per share was 43.9% above analysts' consensus estimates. Is now the time to buy HLF? Find out in our full research report (it's free). Revenue: $1.22 billion vs analyst estimates of $1.23 billion (3.4% year-on-year decline, 0.5% miss) Adjusted EPS: $0.59 vs analyst estimates of $0.41 (43.9% beat) Adjusted EBITDA: $164.9 million vs analyst estimates of $147.2 million (13.5% margin, 12% beat) Revenue Guidance for Q2 CY2025 is $1.26 billion at the midpoint, roughly in line with what analysts were expecting EBITDA guidance for the full year is $640 million at the midpoint, above analyst estimates of $633.6 million Operating Margin: 10.1%, up from 5.7% in the same quarter last year Free Cash Flow was -$18.1 million compared to -$19.1 million in the same quarter last year Organic Revenue rose 1.4% year on year (2.4% in the same quarter last year) Market Capitalization: $693.6 million Herbalife's first quarter results reflected ongoing transformation efforts, as management highlighted the company's shift toward technology-driven personalization and new product offerings. President and incoming CEO Stephan Gratziani emphasized recent acquisitions—especially the launch of the Pro2col digital platform and Link BioSciences' personalized supplement manufacturing—as foundational to Herbalife's strategy. Management attributed Q1's results primarily to cost-saving initiatives and continued distributor engagement, noting, 'Our new distributor growth was up 16% year over year, marking the fourth consecutive quarter of growth.' Looking ahead, Herbalife's forward guidance is shaped by investments in digital platforms, expanded product portfolios, and a focus on operational efficiency. CFO John DeSimone explained that while macroeconomic and foreign exchange headwinds persist, cost controls and the expected rollout of Pro2col should support margin improvement and incremental growth. Management remains cautious on China, with DeSimone stating, 'We're going to wait and see on China before we roll any meaningful upside into our projections.' Herbalife's management underscored several strategic initiatives and market dynamics behind the quarter's financial performance, with a focus on technology integration and distributor engagement. Deviations from Wall Street expectations were mainly due to foreign exchange headwinds and mixed regional volume trends. Acquisitions and Platform Launch: Management completed acquisitions of Pro2col (a digital health platform), Pruvit (ketone supplement IP), and Link BioSciences (personalized supplement manufacturing). The Pro2col platform aims to integrate AI-driven nutrition tracking and personalized health recommendations for distributors and customers. Distributor Engagement Initiatives: Herbalife reported a 16% year-over-year increase in new distributors, attributing this to enhanced training programs and engagement events like the Flex45 Challenge and regional Extravaganzas. Regional Performance Variability: While Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific saw local currency sales growth, reported revenues were constrained by currency headwinds. North America experienced lower volumes, partly offset by price increases, while China faced a 14% volume decline. Cost Savings and Margin Expansion: Adjusted EBITDA margin improved due to pricing actions and reduced raw material costs, as well as restructuring and operational efficiency measures taken in 2024. Product Portfolio Diversification: Management highlighted the rollout of new product categories, particularly through Pruvit's ketone supplements and future Pro2col-branded offerings, as key to expanding Herbalife's customer base and increasing engagement. Management's outlook for the coming quarters centers on leveraging digital health platforms, expanding the product portfolio, and sustaining operational efficiency, while remaining mindful of macroeconomic risks and regional market uncertainties. Digital Platform Expansion: The upcoming launch of the Pro2col digital health platform is expected to drive incremental product sales, deepen customer engagement, and enhance distributor recruitment, though management noted revenue contribution will be limited in early phases. Personalization and Premium Offerings: The integration of Link BioSciences' personalized supplement technology targets a more sophisticated customer segment, including athletes, and is expected to differentiate Herbalife in mature markets over time. Regional Growth Strategy: Management projects continued distributor growth and local currency momentum outside China, but remains cautious on China's recovery and anticipates ongoing foreign exchange volatility as a headwind to reported results. Chasen Bender (Citi): Asked about the monetization strategy and ROI for the Pro2col platform; management replied that while early-stage, revenue streams will include app fees, incremental product sales, and new distributor acquisition, with more detailed modeling expected after commercial launch. Chasen Bender (Citi): Inquired about weaker distributor and volume trends in North America; management attributed this to temporary disruptions from technology launches and expects sequential improvement through the year. John Baumgartner (Mizuho Securities): Questioned the target audience for Link BioSciences; CEO Gratziani explained it will initially serve premium customers and athletes, but expects broader adoption of personalized nutrition over time. Rob Rigby (Bank of America): Asked about tariff impacts and sourcing from China; CFO DeSimone stated tariffs will have a limited financial effect due to U.S.-based manufacturing and duty drawbacks. Doug Lane (Water Tower Research): Queried on capital spending for Pro2col and overall CapEx; management clarified that spending is reprioritized from other projects and fully included in updated guidance, with no permanent elevation in capital expenditures anticipated. In the upcoming quarters, the StockStory team will monitor (1) the rollout and adoption rates of the Pro2col digital platform in the U.S. and subsequent markets, (2) improvements in North American distributor activity and volume trends following recent technology integrations, and (3) signs of stabilization or recovery in China's sales volumes. Progress on personalized supplement offerings and the effectiveness of engagement initiatives like the Flex45 Challenge will also be important indicators of execution. Herbalife currently trades at a forward P/E ratio of 3.3×. Should you load up, cash out, or stay put? See for yourself in our free research report. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Times
29-04-2025
- Automotive
- Business Times
Hong Leong Finance sees over 300% growth in EV loans
[SINGAPORE] Hong Leong Finance (HLF) announced that it has seen a more than 300 per cent increase in electric vehicle (EV) loans, from S$73 million in 2023 to S$314 million in 2024. Besides EV loans, HLF also saw a more than 300 per cent increase in vehicle loans processed digitally, from S$99 million in 2023 to S$400 million in 2024. This was on the back of its new digital platform which connected with major car dealers directly for automotive financing. This new system eliminated the manual paper-based system and redundant data entry. The integration with GovTech's MyInfo, the Singapore government's data management platform, also reduced errors and access to verified personal data. HLF is planning to introduce new capabilities that will enable car dealers to offer online car markets. 'Our innovative digital platform for vehicle loans has proven to be a game changer, offering speed and security for both car dealers and customers,' said Ang Tang Chor, president of HLF.
Zawya
11-03-2025
- Business
- Zawya
ATME completes its first tokenized asset issuance with gold-backed tokens
Manama, Bahrain – Marking a pivotal milestone in its mission to transform capital markets, ATME, the digital assets exchange licensed by the Central Bank of Bahrain (CBB), has successfully completed its first issuance of tokenized real-world assets (RWAs) with gold-backed tokens. With the support of the CBB, this landmark achievement showcases ATME's commitment to driving innovation in the Kingdom's financial sector. ATME issued two tokens, designed for accredited investors, which were acquired by an eligible investor. Each token is backed by one kilogram of gold to provide a modern and secure way to invest in one of the most trusted assets for wealth preservation. The company's tokenized gold offering allows ownership of the physical metal without the complexities of storage or transportation. The tokens represent gold that is securely held in custody until its redemption or trade in ATME's secondary market. Commenting on the milestone, Alex Lola, Chief Executive Officer of ATME remarked, 'Today marks a defining moment for ATME as we launch our first tokenized gold issuance. By combining the timeless value of gold with the transformative potential of blockchain technology, we are unlocking new ways for investors to access and trade high-value assets. This achievement highlights our team's tireless dedication and our collective vision of building. We are excited about the possibilities ahead as we plan to expand our offerings to include more asset classes on our platform.' ATME's first digital asset issuance reflects its strategic focus on increasing efficiency in asset ownership and trading, supported by blockchain technology and robust regulatory compliance. As the company expands its offerings, future issuances will provide investors with access to a wider range of alternative assets. ATME remains focused on driving financial inclusivity and efficiency in the local and regional capital markets. -Ends- About ATME ATME is a licensed digital assets exchange regulated by the Central Bank of Bahrain. Built on the enterprise-grade Hyperledger Fabric (HLF) blockchain framework, ATME brings borderless accessibility and liquidity to private capital markets through the tokenization of Real-World Assets (RWA). The company connects businesses looking for seamless and efficient capital-raising solutions, with institutional investors seeking to diversify their investment portfolios into new high-value asset classes. The private blockchain-based platform provides a highly secure digital marketplace that facilitates the sourcing, trading, tracking, investing, and ownership exchange of tokenized securities, commodities, private equity and more – all within a transparent and compliant ecosystem. Offering a comprehensive range of services designed to optimize the capital raising process and maximize investment potential, ATME is leveraging the liquidity and trading efficiencies presented by RWA tokenization to become a leading player in the regional and international financial marketplace.
